Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem Cells

Osteoblasts and bone marrow adipocytes originate from bone marrow mesenchymal stem cells (BMMSCs) and there appears to be a reciprocal relationship between adipogenesis and osteoblastogenesis. Alterations in the balance between adipogenesis and osteoblastogenesis in BMMSCs wherein adipogenesis is in...

Full description

Saved in:
Bibliographic Details
Main Authors: Shoichiro Kokabu, Jonathan W. Lowery, Eijiro Jimi
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2016/3753581
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849410435907846144
author Shoichiro Kokabu
Jonathan W. Lowery
Eijiro Jimi
author_facet Shoichiro Kokabu
Jonathan W. Lowery
Eijiro Jimi
author_sort Shoichiro Kokabu
collection DOAJ
description Osteoblasts and bone marrow adipocytes originate from bone marrow mesenchymal stem cells (BMMSCs) and there appears to be a reciprocal relationship between adipogenesis and osteoblastogenesis. Alterations in the balance between adipogenesis and osteoblastogenesis in BMMSCs wherein adipogenesis is increased relative to osteoblastogenesis are associated with decreased bone quality and quantity. Several proteins have been reported to regulate this reciprocal relationship but the exact nature of the signals regulating the balance between osteoblast and adipocyte formation within the bone marrow space remains to be determined. In this review, we focus on the role of Transducin-Like Enhancer of Split 3 (TLE3), which was recently reported to regulate the balance between osteoblast and adipocyte formation from BMMSCs. We also discuss evidence implicating canonical Wnt signalling, which plays important roles in both adipogenesis and osteoblastogenesis, in regulating TLE3 expression. Currently, there is demand for new effective therapies that target the stimulation of osteoblast differentiation to enhance bone formation. We speculate that reducing TLE3 expression or activity in BMMSCs could be a useful approach towards increasing osteoblast numbers and reducing adipogenesis in the bone marrow environment.
format Article
id doaj-art-80f5e7ae62434e2da427af581a6c59a7
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-80f5e7ae62434e2da427af581a6c59a72025-08-20T03:35:07ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/37535813753581Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem CellsShoichiro Kokabu0Jonathan W. Lowery1Eijiro Jimi2Division of Molecular Signaling and Biochemistry, Department of Health Improvement, Kyushu Dental University, 2-6-1 Manazuru, Kokurakita-ku, Kitakyushu, Fukuoka 803-8580, JapanDivision of Biomedical Science, College of Osteopathic Medicine, Marian University, 3200 Cold Spring Road, Indianapolis, IN 46222, USADivision of Molecular Signaling and Biochemistry, Department of Health Improvement, Kyushu Dental University, 2-6-1 Manazuru, Kokurakita-ku, Kitakyushu, Fukuoka 803-8580, JapanOsteoblasts and bone marrow adipocytes originate from bone marrow mesenchymal stem cells (BMMSCs) and there appears to be a reciprocal relationship between adipogenesis and osteoblastogenesis. Alterations in the balance between adipogenesis and osteoblastogenesis in BMMSCs wherein adipogenesis is increased relative to osteoblastogenesis are associated with decreased bone quality and quantity. Several proteins have been reported to regulate this reciprocal relationship but the exact nature of the signals regulating the balance between osteoblast and adipocyte formation within the bone marrow space remains to be determined. In this review, we focus on the role of Transducin-Like Enhancer of Split 3 (TLE3), which was recently reported to regulate the balance between osteoblast and adipocyte formation from BMMSCs. We also discuss evidence implicating canonical Wnt signalling, which plays important roles in both adipogenesis and osteoblastogenesis, in regulating TLE3 expression. Currently, there is demand for new effective therapies that target the stimulation of osteoblast differentiation to enhance bone formation. We speculate that reducing TLE3 expression or activity in BMMSCs could be a useful approach towards increasing osteoblast numbers and reducing adipogenesis in the bone marrow environment.http://dx.doi.org/10.1155/2016/3753581
spellingShingle Shoichiro Kokabu
Jonathan W. Lowery
Eijiro Jimi
Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem Cells
Stem Cells International
title Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem Cells
title_full Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem Cells
title_fullStr Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem Cells
title_full_unstemmed Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem Cells
title_short Cell Fate and Differentiation of Bone Marrow Mesenchymal Stem Cells
title_sort cell fate and differentiation of bone marrow mesenchymal stem cells
url http://dx.doi.org/10.1155/2016/3753581
work_keys_str_mv AT shoichirokokabu cellfateanddifferentiationofbonemarrowmesenchymalstemcells
AT jonathanwlowery cellfateanddifferentiationofbonemarrowmesenchymalstemcells
AT eijirojimi cellfateanddifferentiationofbonemarrowmesenchymalstemcells